$SRPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sarepta Therapeutics, Inc.. Get notifications about new insider transactions in Sarepta Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 11,718 | 160,654 | 128,185 | 116.5 K to 128.2 K (+10.06 %) |
Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 29,080 | 398,687 | 116,467 | 87.4 K to 116.5 K (+33.28 %) |
Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 39,006 | 542,183 | 87,387 | 48.4 K to 87.4 K (+80.62 %) |
Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 9,596 | 228,865 | 48,381 | 38.8 K to 48.4 K (+24.74 %) |
Aug 16 2018 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 125.26 | 16,000 | 2,004,211 | 399,250 | 383.3 K to 399.3 K (+4.17 %) |
Aug 08 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 121.02 | 6,000 | 726,120 | 22,766 | 28.8 K to 22.8 K (-20.86 %) |
Aug 08 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 121.02 | 6,800 | 822,936 | 28,071 | 34.9 K to 28.1 K (-19.50 %) |
Aug 08 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 121.02 | 8,501 | 1,028,791 | 38,785 | 47.3 K to 38.8 K (-17.98 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.90 | 37,848 | 526,087 | 27,159 | |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 9,056 | 124,158 | 10,090 | |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 3,096 | 42,446 | 7,431 | |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 136.46 | 37,848 | 5,164,738 | 34,871 | 72.7 K to 34.9 K (-52.05 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.90 | 37,848 | 526,087 | 72,719 | 34.9 K to 72.7 K (+108.54 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 136.46 | 9,056 | 1,235,782 | 34,871 | 43.9 K to 34.9 K (-20.62 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 9,056 | 124,158 | 43,927 | 34.9 K to 43.9 K (+25.97 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 136.46 | 3,096 | 422,480 | 34,871 | 38 K to 34.9 K (-8.15 %) |
Jul 17 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 3,096 | 42,446 | 37,967 | 34.9 K to 38 K (+8.88 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 11,914 | 165,605 | 2,250 | |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 9,944 | 136,332 | 3,895 | |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 11,924 | 163,478 | 3,850 | |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 11,914 | 1,636,030 | 28,766 | 40.7 K to 28.8 K (-29.29 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 11,914 | 165,605 | 40,680 | 28.8 K to 40.7 K (+41.42 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 9,944 | 1,365,510 | 28,766 | 38.7 K to 28.8 K (-25.69 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 9,944 | 136,332 | 38,710 | 28.8 K to 38.7 K (+34.57 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 11,924 | 1,637,404 | 28,766 | 40.7 K to 28.8 K (-29.30 %) |
Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 11,924 | 163,478 | 40,690 | 28.8 K to 40.7 K (+41.45 %) |
Jun 29 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 130.34 | 75,000 | 9,775,500 | 3,170,432 | 3.2 M to 3.2 M (-2.31 %) |
Jun 27 2018 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Payment of Exercise | F | 135.53 | 36,946 | 5,007,291 | 383,250 | 420.2 K to 383.3 K (-8.79 %) |
Jun 11 2018 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Jun 11 2018 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | SVP & Chief Medical ... | Option Exercise | A | 96.23 | 100,000 | 9,623,000 | 100,000 | |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 0.00 | 4,432 | 0 | 0 | |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 89.22 | 1,305 | 116,432 | 31,936 | 33.2 K to 31.9 K (-3.93 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 0.00 | 4,432 | 0 | 33,241 | 28.8 K to 33.2 K (+15.38 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 0.00 | 6,649 | 0 | 0 | |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 89.22 | 2,024 | 180,581 | 47,286 | 49.3 K to 47.3 K (-4.10 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 0.00 | 6,649 | 0 | 49,310 | 42.7 K to 49.3 K (+15.59 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 0.00 | 5,319 | 0 | 0 | |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 89.22 | 1,566 | 139,719 | 34,871 | 36.4 K to 34.9 K (-4.30 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 0.00 | 5,319 | 0 | 36,437 | 31.1 K to 36.4 K (+17.09 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 0.00 | 4,876 | 0 | 0 | |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 89.22 | 1,435 | 128,031 | 28,766 | 30.2 K to 28.8 K (-4.75 %) |
May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 0.00 | 4,876 | 0 | 30,201 | 25.3 K to 30.2 K (+19.25 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 26.24 | 2,031 | 53,293 | 10,066 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 13.90 | 469 | 6,519 | 6,134 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 656 | 53,280 | 28,809 | 29.5 K to 28.8 K (-2.23 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 26.24 | 2,031 | 53,293 | 29,465 | 27.4 K to 29.5 K (+7.40 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 80 | 6,498 | 27,434 | 27.5 K to 27.4 K (-0.29 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 13.90 | 469 | 6,519 | 27,514 | 27 K to 27.5 K (+1.73 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 2,074 | 49,465 | 13,018 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.90 | 403 | 5,602 | 5,590 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 23 | 315 | 70 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 609 | 49,463 | 31,118 | 31.7 K to 31.1 K (-1.92 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 2,074 | 49,465 | 31,727 | 29.7 K to 31.7 K (+6.99 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 68 | 5,523 | 29,653 | 29.7 K to 29.7 K (-0.23 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.90 | 403 | 5,602 | 29,721 | 29.3 K to 29.7 K (+1.37 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 3 | 244 | 29,318 | 29.3 K to 29.3 K (-0.01 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 23 | 315 | 29,321 | 29.3 K to 29.3 K (+0.08 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 26.24 | 1,370 | 35,949 | 11,415 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 835 | 11,607 | 5,001 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 54 | 740 | 6,107 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 241 | 3,304 | 1,485 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 442 | 35,899 | 25,325 | 25.8 K to 25.3 K (-1.72 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 26.24 | 1,370 | 35,949 | 25,767 | 24.4 K to 25.8 K (+5.62 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 142 | 11,533 | 24,397 | 24.5 K to 24.4 K (-0.58 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 835 | 11,607 | 24,539 | 23.7 K to 24.5 K (+3.52 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 9 | 731 | 23,704 | 23.7 K to 23.7 K (-0.04 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 54 | 740 | 23,713 | 23.7 K to 23.7 K (+0.23 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 40 | 3,249 | 23,659 | 23.7 K to 23.7 K (-0.17 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 241 | 3,304 | 23,699 | 23.5 K to 23.7 K (+1.03 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 2,500 | 59,625 | 11,768 | |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 81.22 | 734 | 59,615 | 42,661 | 43.4 K to 42.7 K (-1.69 %) |
Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 2,500 | 59,625 | 43,395 | 40.9 K to 43.4 K (+6.11 %) |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 3,418 | 0 | 10,084 | 6.7 K to 10.1 K (+51.28 %) |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 3,418 | 0 | 5,418 | 2 K to 5.4 K (+170.90 %) |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 71.45 | 97,500 | 6,966,375 | 97,500 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 3,418 | 0 | 3,418 | 0 to 3.4 K |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 3,418 | 0 | 116,534 | 113.1 K to 116.5 K (+3.02 %) |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Basi Guriqbal S. | SVP, Chief Scientif ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 3,418 | 0 | 3,245,432 | 3.2 M to 3.2 M (+0.11 %) |
Dec 05 2017 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 54.29 | 16,400 | 890,356 | 16,400 | |
Dec 04 2017 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 7.38 | 6,667 | 49,202 | 0 | |
Dec 04 2017 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 55.89 | 6,667 | 372,619 | 6,666 | 13.3 K to 6.7 K (-50.00 %) |
Dec 04 2017 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 7.38 | 6,667 | 49,202 | 13,333 | 6.7 K to 13.3 K (+100.02 %) |
Nov 13 2017 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 52.44 | 38,138 | 1,999,957 | 420,196 | 382.1 K to 420.2 K (+9.98 %) |
Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 10,000 | 147,600 | 31,144 | |
Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 55.00 | 10,000 | 550,000 | 27,045 | 37 K to 27 K (-26.99 %) |
Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 10,000 | 147,600 | 37,045 | 27 K to 37 K (+36.98 %) |
Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 11,500 | 169,740 | 41,144 | |
Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 50.00 | 11,500 | 575,000 | 27,045 | 38.5 K to 27 K (-29.84 %) |
Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 11,500 | 169,740 | 38,545 | 27 K to 38.5 K (+42.52 %) |
Sep 25 2017 | SRPT | Sarepta Therapeuti ... | Basi Guriqbal S. | SVP, Chief Scientif ... | Option Exercise | A | 43.90 | 100,000 | 4,390,000 | 100,000 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 8,865 | 0 | 0 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Payment of Exercise | F | 37.88 | 2,882 | 109,170 | 27,045 | 29.9 K to 27 K (-9.63 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 0.00 | 8,865 | 0 | 29,927 | 21.1 K to 29.9 K (+42.09 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 0.00 | 13,298 | 0 | 0 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 37.88 | 6,264 | 237,280 | 40,895 | 47.2 K to 40.9 K (-13.28 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 0.00 | 13,298 | 0 | 47,159 | 33.9 K to 47.2 K (+39.27 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 0.00 | 10,639 | 0 | 0 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 37.88 | 4,642 | 175,839 | 29,298 | 33.9 K to 29.3 K (-13.68 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 0.00 | 10,639 | 0 | 33,940 | 23.3 K to 33.9 K (+45.66 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Option Exercise | M | 0.00 | 35,461 | 0 | 0 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Payment of Exercise | F | 37.88 | 16,703 | 632,710 | 71,229 | 87.9 K to 71.2 K (-19.00 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Buy | M | 0.00 | 35,461 | 0 | 87,932 | 52.5 K to 87.9 K (+67.58 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,752 | 0 | 0 | |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 37.88 | 3,169 | 120,042 | 23,458 | 26.6 K to 23.5 K (-11.90 %) |
Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 0.00 | 9,752 | 0 | 26,627 | 16.9 K to 26.6 K (+57.79 %) |
Jul 28 2017 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 42.50 | 47,058 | 1,999,965 | 382,058 | 335 K to 382.1 K (+14.05 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 1,500 | 35,775 | 14,268 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 7,627 | 181,904 | 125,605 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 32,998 | 458,672 | 56,866 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 9,375 | 128,531 | 24,591 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 1,500 | 35,775 | 33,861 | 32.4 K to 33.9 K (+4.64 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 7,627 | 312,707 | 32,361 | 40 K to 32.4 K (-19.07 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 7,627 | 181,904 | 39,988 | 32.4 K to 40 K (+23.57 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 32,998 | 1,352,918 | 32,361 | 65.4 K to 32.4 K (-50.49 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 32,998 | 458,672 | 65,359 | 32.4 K to 65.4 K (+101.97 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 9,375 | 384,375 | 32,361 | 41.7 K to 32.4 K (-22.46 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 9,375 | 128,531 | 41,736 | 32.4 K to 41.7 K (+28.97 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Sell | S | 41.00 | 10,000 | 410,000 | 52,471 | 62.5 K to 52.5 K (-16.01 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Payment of Exercise | F | 40.93 | 4,349 | 178,005 | 62,471 | 66.8 K to 62.5 K (-6.51 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 1,500 | 22,140 | 52,644 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.90 | 4,388 | 60,993 | 5,098 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.71 | 6,250 | 85,688 | 17,708 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | S | 44.00 | 1,500 | 66,000 | 21,062 | 19.6 K to 21.1 K (+7.67 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 1,500 | 22,140 | 22,562 | 21.1 K to 22.6 K (+7.12 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 44.00 | 4,388 | 193,072 | 21,062 | 25.5 K to 21.1 K (-17.24 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.90 | 4,388 | 60,993 | 25,450 | 21.1 K to 25.5 K (+20.83 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 42.00 | 6,250 | 262,500 | 21,062 | 27.3 K to 21.1 K (-22.88 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.71 | 6,250 | 85,688 | 27,312 | 21.1 K to 27.3 K (+29.67 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 676 | 16,123 | 15,092 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 324 | 4,442 | 93 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 5,944 | 81,492 | 19,146 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 19,056 | 261,258 | 10,527 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 676 | 16,123 | 23,301 | 22.6 K to 23.3 K (+2.99 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 324 | 4,442 | 22,625 | 22.3 K to 22.6 K (+1.45 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 41.00 | 5,944 | 243,704 | 22,301 | 28.2 K to 22.3 K (-21.04 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 5,944 | 81,492 | 28,245 | 22.3 K to 28.2 K (+26.65 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 41.00 | 19,056 | 781,296 | 22,301 | 41.4 K to 22.3 K (-46.08 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 19,056 | 261,258 | 41,357 | 22.3 K to 41.4 K (+85.45 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 2,500 | 34,275 | 15,774 | |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 3,418 | 140,138 | 16,875 | 20.3 K to 16.9 K (-16.84 %) |
Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 2,500 | 102,500 | 20,293 | 22.8 K to 20.3 K (-10.97 %) |